Jan 11, 2016 9:03 am EST Abeona Therapeutics Announces Initial European Regulatory Approvals for Phase 1/2 Gene Therapy Clinical Studies for Patients With Sanfilippo Syndromes Type A (MPS IIIA) and Type B (MPS IIIB)
Dec 1, 2015 9:03 am EST Abeona Therapeutics to Present at Piper Jaffray 27th Annual Healthcare Conference
Nov 18, 2015 9:03 am EST Abeona Therapeutics to Present at Jefferies 2015 Global Healthcare Conference
Nov 17, 2015 9:03 am EST Abeona Therapeutics Reports Financial Results and Highlights for Third Quarter 2015
Oct 6, 2015 9:03 am EDT Abeona Therapeutics Announces License for Next Generation AAV Delivery Vector for Fanconi Anemia and Rare Blood Disease Platform
Sep 3, 2015 9:03 am EDT Abeona Therapeutics to Present at 2015 Rodman & Renshaw Annual Global Investment Conference
Aug 24, 2015 9:03 am EDT Abeona Therapeutics to Present at the 2015 Sidoti Emerging Growth Conference
Aug 17, 2015 9:03 am EDT Abeona Therapeutics Announces Recent Highlights and Second Quarter 2015 Conference Call
Aug 3, 2015 9:03 am EDT Abeona Therapeutics Announces Closing of Upsized $15.5 Million Equity Financing With Institutional Investors and Management
